Up to now, scholars only reported somatic variances of JAK2 and TIF1g (TRIM33) that may possibly correlate with dermatomyositis, but most of the studies were case reports or from malignancy-associated dermatomyositis (29, 30). This evidence concerns the gene JAK2 and cancer.